PAIN:TSXV, Vector Science and Therapeutics Corp.
Why PAIN stock fell on November 18
Vector Science and Therapeutics Corp. fell 16.6%
on Wednesday, November 18, 2026, on 139,650 shares.
The headline around the move:
PAIN stock overview
Vector Science and Therapeutics Corp. (PAIN:TSXV) closed at $2.53 on November 19, 2026,
down 1.17% on the day.
The stock trades 21.7% below its 52-week high of $3.23
and 622.9% above its 52-week low of $0.350.
Over the past year, it gained 583.8%.
Vector Science and Therapeutics Corp. is part of the Funds & Shells sector.
Key figures
- Price
- $2.53
- Day change
- -1.17%
- Volume
- 175,677
- Average volume
- 119,301
- Market cap
- 395M+
- 52-week range
- $0.350 – $3.23
- 50-day average
- $1.93
- 200-day average
- $1.79
Price action over the past year
In 142 trading sessions since April 29, 2026, PAIN closed higher on 66 days (46%).
Its best day was April 29, 2026 (+31.08%) and its worst was November 18, 2026 (-16.61%).
The stock moved 10% or more in a single session 21 times.
Recent signals
PAIN news
-
Nov 18, 2026:
Andrews Research & Education Foundation and Vector Science and Therapeutics Announce Collaboration for the Clinical Evaluation and Development of Peptides for Sports Medicine and Regenerative Medicine Applications
-
Nov 16, 2026:
Sports Medicine Pioneer Dr. James Andrews and Vector Chairman Tommy Thompson, former U.S. Secretary of Health and Human Services, to Announce Major Medical Development Involving Peptides
-
Oct 22, 2026:
Vector Science and Therapeutics Corp. Introduces Peptide-Matrix Microneedle Technology for Targeted Transdermal Delivery of Peptides
-
Oct 19, 2026:
Vector Science and Therapeutics Corp. Appoints Angus Jackson as Managing Director of Corporate Development
-
Oct 14, 2026:
Vector Science & Therapeutics Corp. Appoints Russell Starr as President
-
Oct 13, 2026:
Vector Science and Therapeutics Corp. Announces Collaboration and SAFE Investment in Whoopi Wellness, Inc.
-
Oct 7, 2026:
Vector Science and Therapeutics Corp. Announces Collaboration with SAFE Investment in Gary Payton's Scoreboard
-
Sep 25, 2026:
Vector Science and Therapeutics Corp. Issues Options
About Vector Science and Therapeutics Corp.
Opensesame Acquisition Corp is a capital pool company.
Similar stocks
Find more stocks like PAIN with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.